These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36497267)

  • 1. Down-Regulation of lncRNA MBNL1-AS1 Promotes Tumor Stem Cell-like Characteristics and Prostate Cancer Progression through miR-221-3p/CDKN1B/C-myc Axis.
    Liu J; Niraj M; Wang H; Zhang W; Wang R; Kadier A; Li W; Yao X
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA MBNL1-AS1 regulates proliferation, migration, and invasion of cancer stem cells in colon cancer by interacting with MYL9 via sponging microRNA-412-3p.
    Zhu K; Wang Y; Liu L; Li S; Yu W
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):101-114. PubMed ID: 31255531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis.
    Ding Y; Li Y; Duan Y; Wang W; Zheng W; Cheng W; Qi Y; Feng J; Chen Z; Yu T; Hu A; Wang T; Li M; Zhang H; Li Y; Ma F; Guo B
    J Oncol; 2022; 2022():9999343. PubMed ID: 35518784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.
    Su J; Chen D; Ruan Y; Tian Y; Lv K; Zhou X; Ying D; Lu Y
    Bioengineered; 2022 Mar; 13(3):6978-6995. PubMed ID: 35311623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway.
    Xu L; Zhu S; Tang A; Liu W
    Inflamm Res; 2021 Feb; 70(2):217-227. PubMed ID: 33454803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis.
    Fang J; Jiang G; Mao W; Huang L; Huang C; Wang S; Xue H; Ke J; Ni Q
    Bioengineered; 2022 Feb; 13(2):3707-3723. PubMed ID: 35094653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH; Ji YF; Qiu XJ
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 14. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis.
    Wang B; Sun X; Huang KJ; Zhou LS; Qiu ZJ
    World J Gastroenterol; 2021 May; 27(17):1993-2014. PubMed ID: 34007135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSCAM-AS1 promotes the development of prostate cancer.
    Cheng L; Li S; Jiang D; Zhang J
    Discov Oncol; 2024 Apr; 15(1):113. PubMed ID: 38605206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MBNL1-AS1 functions as an alternative atherosclerosis biomarker in elderly hypertensive patients and regulates vascular smooth muscle cell function.
    Song Y; Zhu X; Cai X; Yu Y; Hu D
    Minerva Cardiol Angiol; 2024 Oct; ():. PubMed ID: 39377700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB; Liu N
    Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA KCNMB2-AS1 Promotes SMAD5 by Targeting miR-3194-3p to Induce Bladder Cancer Progression.
    Chen YS; Xu YP; Liu WH; Li DC; Wang H; Li CF
    Front Oncol; 2021; 11():649778. PubMed ID: 34026626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.